Drug Delivery Systems

Drug Delivery Systems

METHODS

IN

MOLECULAR

B I O L O G Ytm

John M. Walker, Series Editor
459. Prion Protein Protocols, edited by
Andrew F. Hill, 2008
458. Artificial Neural Networks: Methods and
Applications, edited by David S. Livingstone,
2008
457. Membrane Trafficking, edited by Ales
Vancura, 2008
456. Adipose Tissue Protocols, Second Edition, edited by Kaiping Yang, 2008
455. Osteoporosis, edited by Jennifer J. Westendorf,
2008
454. SARS- and Other Coronaviruses: Laboratory
Protocols, edited by Dave Cavanagh, 2008
453. Bioinformatics, Volume 2: Structure, Function, and Applications, edited by Jonathan M. Keith,
2008
452. Bioinformatics, Volume 1: Data, Sequence
Analysis, and Evolution, edited by Jonathan M.
Keith, 2008
451. Plant Virology Protocols: From Viral
Sequence to Protein Function, edited by Gary
Foster, Elisabeth Johansen, Yiguo Hong, and
Peter Nagy, 2008
450. Germline Stem Cells, edited by Steven X. Hou and Shree Ram Singh, 2008
449. Mesenchymal Stem Cells: Methods and Protocols, edited by Darwin J. Prockop,
Douglas G. Phinney, and Bruce A. Brunnell,
2008
448. Pharmacogenomics in Drug Discovery and Development, edited by Qing Yan, 2008
447. Alcohol: Methods and Protocols, edited by
Laura E. Nagy, 2008
446. Post-translational Modification of Proteins:
Tools for Functional Proteomics, Second
Edition, edited by Christoph Kannicht, 2008
445. Autophagosome and Phagosome, edited by
Vojo Deretic, 2008
444. Prenatal Diagnosis, edited by Sinhue Hahn and
Laird G. Jackson, 2008
443. Molecular Modeling of Proteins, edited by
Andreas Kukol, 2008
442. RNAi: Design and Application, edited by
Sailen Barik, 2008
441. Tissue Proteomics: Pathways, Biomarkers, and Drug Discovery, edited by Brian Liu,
2008
440. Exocytosis and Endocytosis, edited by Andrei I.
Ivanov, 2008
439. Genomics Protocols: Second Edition, edited by Mike Starkey and Ramnanth Elaswarapu,
2008

438. Neural Stem Cells: Methods and

References: 1. Crommelin, D., van Winden, E., Mekking, A. (2002) Delivery of pharmaceutical proteins. In: Aulton, M 2. Shen, W. C., Wan, J., Ekrami, H. (1992) Means to enhance penetration (3). Enhancement of polypeptide and protein absorption by macromolecular carriers via endocytosis and transcytosis 4. Hollinger, M. A. (1985) Respiratory pharmocology and toxicology. Saunders, Philadelphia, pp 5. Shoyele, S. A., Slowey, A. (2006) Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery 6. Edwards, D. A., Hanes, J., Caponetti, G., Hirach, J., Ben-Jebria, A. (1997) Large porous particles for pulmonary drug delivery. Science 276, 1868–1871. 7. Aquiar, M. M. G., Rodrigues, J. M., Cunha, A. S. (2004) Encapsulation of insulin-cyclodextrin complex in PLGA microspheres: a new approach to prolonged pulmonary insulin delivery. 8. Koushik, K., Kompella, U. B. (2004) Preparation of large porous deslorelin-PLGA microparticles with reduced residual solvent and cellular uptake using supercritical CO2 process. 9. Courrier, H. M., Butz, N., Vandamme, Th. F. (2002) Pulmonary drug delivery systems: recent developments and prospects 10. Garcia-Contreras, L., Morcol, T., Bell, S. J. D., Hickey, A. J. (2003) Evaluation of novel particles as pulmonary delivery systems for insulin in rats. AAPS PharmSci. 5(2), Article 9. 11. Leach, C. L., Patton, J. S., Perkins, K. M., Kuo, M., Bueche, B., Guo, L., Bentley, M. D., (2002) PEG-insulin delivered by the pulmonary route provides prolonged systemic activity 12. Kwon, J. H., Lee, B. H., Lee, J. J., Kim, C. W. (2004) Insulin microcrystal suspension as a long acting formulation for pulmonary delivery 14. Hinds, K. D., Kim, S. W. (2002) Effects of PEG conjugation on insulin properties. Adv. Drug Deliv 15. Kim, H. K., Chung, H. J., Park, T. J. (2006) Biodegradable polymeric microspheres with open/closed pores for sustained release of human growth hormone 16. Wang, J., Chua, K. M., Wang, C. H. (2004) Stabilization and encapsulation of human immunoblobulin G into biodegradable microspheres 17. Sharma, A., Sharma, U. S. (1997) Liposomes in drug delivery: progress and limitations. Int. 18. Niven, R. W., Speer, M., Schreier, H. (1991) Nebulization of liposomes. II. The effects of size and modelling of solute release profiles 19. Allen T. M. (1998) Liposomal drug formulations. Rationale for development and what we can expect for the future 20. Labiris, N. R., Dolovich, M. B. (2002) Pulmonary drug delivery. Part II: The role of inhalation delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications.